Request Demo
Last update 20 Mar 2025
Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Combination vaccine, Live attenuated vaccine, Prophylactic vaccine |
Synonyms Measles, Mumps and Rubella Combined Vaccine,Live, 麻腮风联合减毒活疫苗（上海生物制品研究所） |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)NCT06399003
A Phase III, Multi-Center, Randomized, Observer-Blind, Active Controlled Non-Inferiority Study to Evaluate the Immunogenicity and Safety of SIBP's MMR Vaccine Compared to GSK MMR Vaccine in Children, 9-11 Months of Age
NCT04111432
A Randomized, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Measles, Mumps, and Rubella Combined Live Attenuated Vaccine/ Encephalitis Live Attenuated Vaccine
100 Clinical Results associated with Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
Login to view more data
100 Deals associated with Measles, mumps and rubella combined vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Measles | China | 15 Nov 2007 | |
| Mumps | China | 15 Nov 2007 | |
| Rubella | China | 15 Nov 2007 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Measles | Phase 3 | Kenya | 28 Jun 2024 | |
| Mumps | Phase 3 | Kenya | 28 Jun 2024 | |
| Rubella | Phase 3 | Kenya | 28 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free